Novartis is set to invest $23 billion in US-based manufacturing and research and development (R&D) over the next five years, ...

Swiss pharmaceutical giant Novartis announced it will spend $23 billion to build and expand 10 facilities in the United ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...

Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Swiss pharmaceutical giant Novartis said it plans to invest $23 billion in the construction and expansion of U.S. facilities, ...

The Swiss pharmaceutical company Novartis has announced significant investments in the US, days after President Donald Trump threatened to impose tariffs on foreign drugs. The company announced ...

The pharmaceutical firm will establish a research innovation hub in California, and manufacturing facilities in Florida, ...

It joins a growing number of multinational drug companies to announce investments in the US. Read more at straitstimes.com.

It is part of a planned $23 billion investment over the next five years aimed at expanding its U.S.-based infrastructure.

Novartis AG NVS, a Swiss pharma giant, is scheduled to report first-quarter 2025 results on April 29, 2025. The Zacks ...